Shire plc (SHPG) has risen sharply, recording gains of 3.94% in the past 4 weeks. However, the stock has corrected -0.97% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 2.88% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.
The stock has recorded a 20-day Moving Average of 1.67% and the 50-Day Moving Average is 6.26%. Shire plc (NASDAQ:SHPG): stock turned positive on Friday. Though the stock opened at $197.84, the bulls momentum made the stock top out at $199.11 level for the day. The stock recorded a low of $196.96 and closed the trading day at $198.93, in the green by 0.10%. The total traded volume for the day was 547,487. The stock had closed at $198.74 in the previous days trading.
The company Insiders own 2% of Shire plc shares according to the proxy statements. Institutional Investors own 31.04% of Shire plc shares. Also, Brokerage firm Goldman Sachs maintains its rating on Shire plc (NASDAQ:SHPG). The shares have been rated Buy. The rating by the firm was issued on June 28, 2016.
Shire plc is a biopharmaceutical company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other specialty conditions. The Company commercializes its products in the areas of Neuroscience, Gastrointestinal (GI), Rare Diseases and Other therapeutic areas. The Companys products include VYVANSE/VENVANSE/ELVANSE/TYVENSE/ELVANSE VUXEN/ADUVANZ (lisdexamfetamine dimesylate), ADDERALL XR (mixed salts of a single-entity amphetamine), INTUNIV (extended release guanfacine), EQUASYM (methylphenidate hydrochloride) modified release (XL), BUCCOLAM, LIALDA (mesalamine)/ MEZAVANT(mesalazine), PENTASA (mesalamine), RESOLOR (prucalopride), REPLAGAL (agalsidase alfa), VPRIV (velaglucerase alfa), FIRAZYR (icatibant), CINRYZE C1 esterase inhibitor (human), FOSRENOL (lanthanum carbonate), XAGRID/ AGRYLIN (anagrelide hydrochloride) and PLENADREN (modified release hydrocortisone).